US healthcare : navigating through the headwinds

<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<rdf:Description>
<dc:creator>McKinsey & Company</dc:creator>
<dc:date>2025</dc:date>
<dc:description xml:lang="es">Sumario: In 2024, US healthcare deal activity continued to slow after its peak in 2021, with total deals declining roughly 30 percent year over year. Headwinds included high multiple expectations, given prior valuations in key sectors (for example, healthcare services and technology); continued margin pressure for payers and providers, which limited the funds available for acquisitions; and regulatory uncertainty. In this article, we assess US deal activity in 2024, identify important developments since 2023, and highlight key insights across leading sectors</dc:description>
<dc:identifier>https://documentacion.fundacionmapfre.org/documentacion/publico/es/bib/187336.do</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>McKinsey & Company</dc:publisher>
<dc:rights xml:lang="es">InC - http://rightsstatements.org/vocab/InC/1.0/</dc:rights>
<dc:subject xml:lang="es">Sanidad</dc:subject>
<dc:subject xml:lang="es">Fusiones y adquisiciones</dc:subject>
<dc:subject xml:lang="es">Asistencia sanitaria</dc:subject>
<dc:subject xml:lang="es">Análisis transaccional</dc:subject>
<dc:subject xml:lang="es">Operaciones financieras</dc:subject>
<dc:subject xml:lang="es">Sectores económicos</dc:subject>
<dc:subject xml:lang="es">Estados Unidos</dc:subject>
<dc:type xml:lang="es">Books</dc:type>
<dc:title xml:lang="es">US healthcare : navigating through the headwinds</dc:title>
<dc:format xml:lang="es">9 p.</dc:format>
<dc:coverage xml:lang="es">Estados Unidos</dc:coverage>
</rdf:Description>
</rdf:RDF>